3,292
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line

ORCID Icon, , , , , , , , , , , , , , , , & ORCID Icon show all
Article: e1638210 | Received 03 Jan 2019, Accepted 25 Jun 2019, Published online: 13 Jul 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.